Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mary Eapen, Ryotaro Nakamura et al.|Journal of Clinical Oncology|2017Cited by 325
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R. McCurdy, Mary Eapen, Mei-Jie Zhang et al.|Blood Advances|2018Cited by 96
Comparative Analysis of Calcineurin Inhibitor–Based Methotrexate and Mycophenolate Mofetil–Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Betty K. Hamilton, Ying Liu et al.|Biology of Blood and Marrow Transplantation|2018Cited by 51
Acquired Glanzmann's thrombasthenia with optimal response to rituximab therapyMelhem Solh, Yvonne Datta, Craig Mescher et al.|American Journal of Hematology|2011Cited by 13
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research ReportHaesook T. Kim, Michael R. Grunwald, Kwang Woo Ahn et al.|Clinical Cancer Research|2019Cited by 13